Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank75
5Y CAGR-31.6%
Year-over-Year Change
Year-over-year book value per share growth
5Y CAGR
-31.6%/yr
Long-term compound
Percentile
P75
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
3 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 59.24% |
| 2024 | 12.53% |
| 2023 | 2.39% |
| 2022 | -31.97% |
| 2021 | -13.53% |
| 2020 | 394.77% |
| 2019 | -81.41% |
| 2018 | -32.00% |
| 2017 | 230.93% |
| 2016 | -31.97% |